
Global enteral nutrition market will reach $19.75 billion by 2030, growing by 8.9% annually over 2020-2030 driven by the increasing incidence of malnutrition, rising number of patients suffering with chronic diseases, and surge in adoption of enteral nutrition over parenteral nutrition due to lower cost and complications of enteral nutrition.
Highlighted with 122 tables and 89 figures, this 195-page report “Global Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Region.
Based on Nutrient, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Protein Based Nutrition
o Standard Protein Diet
o High Protein Supplement
o Protein for Diabetic Patients
o Other Protein-based Nutitions
• Carbohydrates Based Nutrition
• Fat Based Nutrition
• Vitamin Based Nutrition
• Other Nutrition Types
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Critical Care
• Diabetes
• Neurology
• Oncology
• Other Applications
Based on Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Enteral Nutrition for Chronic Illness
• Enteral Nutrition with Standard Formula
Based on Product Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liquid Enteral Nutrition
• Powder Enteral Nutrition
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pediatric
• Adults
• Geriatric
Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Distribution by Hospitals
• Distribution by Retail Pharmacies
• Distribution by Online Pharmacies
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Colombia, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Nutrient, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Global Health Products, Inc.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser (Mead Johnson & Company LLC)
Victus, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter’s Fiver Forces Analysis 38
3 Segmentation of Global Market by Nutrient 42
3.1 Market Overview by Nutrient 42
3.2 Protein Based Nutrition 44
3.2.1 Standard Protein Diet 46
3.2.2 High Protein Supplement 47
3.2.3 Protein for Diabetic Patients 48
3.2.4 Other Protein-based Nutitions 49
3.3 Carbohydrates Based Nutrition 50
3.4 Fat Based Nutrition 51
3.5 Vitamin Based Nutrition 52
3.6 Other Nutrition Types 53
4 Segmentation of Global Market by Application 54
4.1 Market Overview by Application 54
4.2 Critical Care 56
4.3 Diabetes 57
4.4 Neurology 58
4.5 Oncology 59
4.6 Other Applications 60
5 Segmentation of Global Market by Category 61
5.1 Market Overview by Category 61
5.2 Enteral Nutrition for Chronic Illness 63
5.3 Enteral Nutrition with Standard Formula 64
6 Segmentation of Global Market by Product Form 65
6.1 Market Overview by Product Form 65
6.2 Liquid Enteral Nutrition 67
6.3 Powder Enteral Nutrition 68
7 Segmentation of Global Market by End User 69
7.1 Market Overview by End User 69
7.2 Pediatric 71
7.3 Adults 72
7.4 Geriatric 73
8 Segmentation of Global Market by Distribution Channel 74
8.1 Market Overview by Distribution Channel 74
8.2 Distribution by Hospitals 76
8.3 Distribution by Retail Pharmacies 77
8.4 Distribution by Online Pharmacies 78
9 Segmentation of Global Market by Region 79
9.1 Geographic Market Overview 2019-2030 79
9.2 North America Market 2019-2030 by Country 83
9.2.1 Overview of North America Market 83
9.2.2 U.S. 87
9.2.3 Canada 90
9.2.4 Mexico 92
9.3 European Market 2019-2030 by Country 94
9.3.1 Overview of European Market 94
9.3.2 Germany 98
9.3.3 UK 100
9.3.4 France 102
9.3.5 Spain 104
9.3.6 Italy 106
9.3.7 Russia 108
9.3.8 Rest of European Market 110
9.4 Asia-Pacific Market 2019-2030 by Country 112
9.4.1 Overview of Asia-Pacific Market 112
9.4.2 Japan 116
9.4.3 China 120
9.4.4 Australia 123
9.4.5 India 125
9.4.6 South Korea 128
9.4.7 Rest of APAC Region 131
9.5 South America Market 2019-2030 by Country 133
9.5.1 Argentina 136
9.5.2 Brazil 138
9.5.3 Colombia 140
9.5.4 Rest of South America Market 142
9.6 MEA Market 2019-2030 by Country 143
9.6.1 UAE 146
9.6.2 Saudi Arabia 148
9.6.3 South Africa 150
9.6.4 Other National Markets 152
10 Competitive Landscape 153
10.1 Overview of Key Vendors 153
10.2 New Product Launch, Partnership, Investment, and M&A 156
10.3 Company Profiles 157
Abbott Laboratories 157
B. Braun Melsungen AG 159
Baxter International, Inc. 163
Danone S.A. 166
Fresenius Kabi AG 169
Global Health Products, Inc. 173
Hormel Foods Corporation 175
Meiji Holdings Co., Ltd. 177
Nestle S.A. 179
Reckitt Benckiser (Mead Johnson & Company LLC) 184
Victus, Inc. 187
11 Investing in Global Market: Risk Assessment and Management 189
11.1 Risk Evaluation of Global Market 189
11.2 Critical Success Factors (CSFs) 192
Related Reports and Products 195
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Global Health Products, Inc.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser (Mead Johnson & Company LLC)
Victus, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Ěý
Ěý
*If Applicable.
